BSTG - Biostage, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue--82118
Cost of Revenue--116139
Gross Profit---34-21
Operating Expenses
Research Development3,9167,5887,6034,786
Selling General and Administrative3,7253,8804,4896,894
Non Recurring----
Total Operating Expenses7,64111,46812,20811,819
Operating Income or Loss-7,641-11,468-12,126-11,701
Income from Continuing Operations
Total Other Income/Expenses Net112-448547-3
Earnings Before Interest and Taxes-7,641-11,468-12,126-11,701
Interest Expense----
Income Before Tax-7,529-11,916-11,579-11,704
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-7,529-11,916-11,579-11,704
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-7,529-11,916-11,579-11,704
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-7,529-11,916-11,579-11,704